✓Strengths
- Profit has compounded about 21% a year over five years.
- Sales have compounded about 16% a year over five years.
- Has paid a dividend in each of the last 3 years on record.
!Watch-points
- Higher leverage: debt-to-equity of 5.75 is above 1.
- Thin interest cover: operating profit covers interest only about 1.5 times.
- Return on equity is on the lower side at 8.6%.
- Return on capital employed is on the lower side at 7.4%.
- Net profit margin is slim at 3.3%.
- Current ratio of 0.25 is below 1, so current liabilities exceed current assets.
These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.
Forensic Checks
Altman Z-ScoreDistress zone
0.24
In Altman’s study, scores in this range were associated with a higher incidence of financial distress.
Computed without the market-value term.
Piotroski F-ScoreWeak
3 / 5
The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.
Based on 5 of the 9 signals — the rest need data not available for this stock.
These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.
Key Ratios
Book Value₩ 12,887.85
ROCE7.36%
ROE8.62%
Debt to Equity5.75
Current Ratio0.25
EPS₩ 1,111.00
PAT Margin3.30%
ICR1.47
Compounded Sales Growth
10 Years
—
5 Years
15.96%
3 Years
—
TTM
—
Compounded Profit Growth
10 Years
—
5 Years
21.11%
3 Years
—
TTM
—
Stock Price CAGR
10 Years
—
5 Years
—
3 Years
—
1 Year
—
Return on Equity
10 Years
—
5 Years
—
3 Years
—
Last Year
8.62%